Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Gefitinib along with c-MET inhibited demonstrated additive synergetic effect in cell line models
Rather than increasing CJC-1295 above its saturation dose, adding a second peptide that activates a completely different receptor (the ghrelin/GHS receptor) amplifies total GH release more efficiently
Bone loss during the fat loss period (fat loss model in obese rats) Experimental Design: Animals: Obese SD rats induced by high-fat diet were randomly divided into an obesity control group, a simple weight loss group (30% calorie restriction), and a weight loss+AOD 9604 group (500 g/kg/day)
A 12-year randomized clinical study by Korkushko et al
Desired Dose (mcg) Your exact target research dose in micrograms
Drawing from the perspectives of representatives from science, policy, and action in each city-region, the study applies the analytical framework proposed by Moragues-Faus (2024), which emphasizes the principles of Time, Place, Relations, Diversity, and Power
US$ 21.78
US$ 22.74
US$ 28.40
US$ 25.95
